Captis Biotechnology addresses an unmet medical need: an accurate method for detecting and treating deadly diseases. Captis has developed a breakthrough in new diagnostic technology, using biomarkers, that can potentially change the way ovarian cancer is diagnosed, providing a reliable way to detect early stages of the disease.